<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0236217</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6077</journal-id>
<journal-id journal-id-type="nlm-ta">Neuropharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0028-3908</issn>
<issn pub-type="epub">1873-7064</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30176250</article-id>
<article-id pub-id-type="pmc">7476513</article-id>
<article-id pub-id-type="doi">10.1016/j.neuropharm.2018.08.033</article-id>
<article-id pub-id-type="manuscript">NIHMS1512236</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cav1.2 L-type calcium channels regulate stress coping behavior via serotonin neurons</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ehlinger</surname>
<given-names>Daniel G.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="corresp" rid="CR1">c</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Commons</surname>
<given-names>Kathryn G.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a.</label> Department of Anesthesiology, Perioperative and Pain Medicine, Boston Childrenâ€™s Hospital, Boston, MA.</aff>
<aff id="A2"><label>b.</label> Department of Anesthesia, Harvard Medical School, Boston, MA.</aff>
<author-notes>
<corresp id="CR1"><label>c.</label> Corresponding Author <email>Daniel.ehlinger@childrens.harvard.edu</email>, address: 300 Longwood Ave, Boston, MA 02115, phone: 1-617-919-4271</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>23</day>
<month>6</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>07</day>
<month>9</month>
<year>2020</year>
</pub-date>
<volume>144</volume>
<fpage>282</fpage>
<lpage>290</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuropharm.2018.08.033-->
<abstract id="ABS1">
<p id="P1">Human genetic variation in the gene <italic>CACNA1C,</italic> which codes for the alpha-1c subunit of Cav1.2 L-type calcium channels (LTCCs), has been broadly associated with enhanced risk for neuropsychiatric disorders including major depression, bipolar and schizophrenia. Little is known about the specific neural circuits through which <italic>CACNA1C</italic> and Cav1.2 LTCCs impact disease etiology. However, serotonin (5-HT) neurotransmission has been consistently implicated in these neuropsychiatric disorders and Cav1.2 LTCCs may influence 5-HT neuron activity during relevant behavioral states such as stress. We utilized a temporally controlled and 5-HT neuron specific Cacna1c knockout mouse model to assess stress-coping behavior using the forced swim test and dorsal raphe (DR) 5-HT neuron Fos activation. Furthermore, we assessed 5-HT1A receptor function and feedback inhibition of the DR following administration of the 5-HT1A antagonist WAY-100635. We find that 5-HT neuron Cacna1c knockout disrupts active-coping behavior in the forced swim test and that this behavioral effect is rescued by blocking 5-HT1A receptors. Moreover, Cacna1c knockout mice display enhanced Fos expression in caudal DR 5-HT neurons and an enhanced response to a 5-HT1A receptor antagonist in rostral DR 5-HT neurons, indicating that loss of Cacna1c disrupts both 5-HT neuron activation and 5-HT1A dependent feedback inhibition across the caudal to rostral DR. Collectively, these results reveal an important role for 5-HT neuron Cav1.2 LTCCs in stress-coping behavior and 5-HT1A receptor function. This suggests that alterations in <italic>CACNA1C</italic> function or expression could influence the development or treatment of neuropsychiatric disorder through serotonergic mechanisms.</p>
</abstract>
<kwd-group>
<kwd>Serotonin</kwd>
<kwd>Dorsal Raphe</kwd>
<kwd>Cacna1c</kwd>
<kwd>L-type calcium channels</kwd>
<kwd>Cav1.2</kwd>
<kwd>psychiatric disorders</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>